Day: July 27, 2021

BOCA RATON, Fla., July 27, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today the closing of its previously announced underwritten public offering of 10,454,546 shares of common stock of the Company, including the exercise in full by the underwriter of the option to purchase an additional 1,363,636 shares of common stock, at a price to the public of $0.55 per share. H.C. Wainwright & Co. acted as the sole book-running manager for the offering. The gross proceeds to the Company, before deducting underwriting discounts and commissions and offering expenses, including the exercise in full of the underwriter’s option to purchase...

FREMONT, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX, ENVXW), the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today announced it will release its second quarter fiscal year 2021 financial results on Tuesday, August 10, 2021 after the close of the market. Enovix will hold a conference call at 2:00 PM PT / 5:00 PM ET on the same day to discuss the company’s business and financial results. Live Dial-in Details:North America (toll-free): +1 (833) 865-1567International: +1 (574) 990-9731Conference ID: 9483164 Enovix will post its Letter to Shareholders with financial results and management commentary on its investor relations website at https://ir.enovix.com shortly after 1:00 PM PT on Tuesday, August 10, 2021 and will issue a press release outlining...

BETHLEHEM, Pa., July 27, 2021 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, August 3, 2021. August 3, 2021 Schedule: 4:01 p.m. ET – 2021 second quarter financial results press release will be distributed. 4:50 p.m. ET – To participate in the conference call, dial (888) 771-4371 (Domestic) or (847) 585-4405 (International) and reference Conference ID # 50205303. 5:00 p.m. ET – Conference call and simultaneous Webcast begins. The conference call will also be available via webcast, and may be accessed on the Investor Relations page of OraSure’s website, www.orasure.com. Please click on the webcast link and follow the prompts for...

AUSTIN, Texas, July 27, 2021 (GLOBE NEWSWIRE) — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.Thursday, August 12 at 4:30 pm ETDomestic: 877-407-4018International: 201-689-8471Conference ID: 13720544Webcast: http://public.viavid.com/index.php?id=145272About Aspira Women’s Health Inc.Aspira Women’s Health Inc. (formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize...

IRVINE, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today it will release its second quarter financial results on Tuesday, August 10, 2021. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the live call via telephone by dialing (833)-519-1265 for domestic callers or (914)-800-3838 for international callers, using conference ID: 1160795. The live webinar of the call may be accessed by visiting the Events Section of the Inari investor relations website at ir.inarimedical.com....

SANTA BARBARA, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Tuesday, August 10, 2021. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time. The dial-in numbers are 1 (844) 464-3933 for domestic callers and 1 (765) 507-2612 for international callers. The conference ID is 8957315. A live webcast of the conference call will be available on the Investor Relations section of the Company’s website at www.sientra.com. The webcast will be archived on the website following the completion of the call.   About SientraHeadquartered in Santa Barbara,...

HOUSTON, July 27, 2021 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (“Gulf Island” or the “Company”) (NASDAQ: GIFI) will report second quarter 2021 results after the market close on Tuesday, August 10, 2021. Gulf Island management will hold a conference call on Tuesday, August 10, 2021, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss the Company’s financial results. The call will be available by webcast and can be accessed on Gulf Island’s website at http://www.gulfisland.com. Participants may also join the call by calling 1.866.269.4260 and requesting the “Gulf Island” conference call. A replay of the webcast will be available on the Company’s website for seven days after the call. About Gulf Island Gulf Island is a leading fabricator of complex steel structures and modules and provider of project management,...

GAITHERSBURG, Md., July 27, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced it plans to report second quarter financial results and provide a corporate update on Monday, August 9, 2021, via press release, after market close. The press release will be accessible under the investor section of the NexImmune’s website at www.neximmune.com. About NexImmune NexImmune is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent, and durable immune response. The backbone of NexImmune’s approach is a proprietary Artificial Immune...

PITTSBURGH, July 27, 2021 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq: IIVI), a global leader in engineered materials and optoelectronic components, announced today that the Company will hold a live webcast and conference call on Tuesday, August 10, 2021, at 9:00 a.m. EDT. The webcast and call will be hosted by Dr. Vincent D. (Chuck) Mattera, Jr., Chief Executive Officer; Mary Jane Raymond, Chief Financial Officer; and Dr. Giovanni Barbarossa, Chief Strategy Officer and President, Compound Semiconductors. The fourth-quarter results for FY 2021 will be released before the market opens on Tuesday, August 10, 2021, and will be posted on the Company’s website at www.ii-vi.com/investor-relations. Webcast URL: Individuals wishing to participate in the webcast can access the event at the Company’s website by visiting www.ii-vi.com or...